DaVita (DVA) Tops Q1 EPS by 6c
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $179.17 -1.28%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q1 EPS of $0.92, $0.06 better than the analyst estimate of $0.86. Revenue for the quarter came in at $3.58 billion versus the consensus estimate of $3.51 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- zSpace, Inc. (ZSPC) Reports Q2 results
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
